Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001802768-24-000058
Filing Date
2024-11-06
Accepted
2024-11-06 09:24:14
Documents
73
Period of Report
2024-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q rprx-20240930.htm   iXBRL 10-Q 2285495
2 EX-31.1 rprx-20240930ex311.htm EX-31.1 9257
3 EX-31.2 rprx-20240930ex312.htm EX-31.2 9293
4 EX-32 rprx-20240930ex32.htm EX-32 5018
  Complete submission text file 0001802768-24-000058.txt   10348954

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT rprx-20240930.xsd EX-101.SCH 73327
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT rprx-20240930_cal.xml EX-101.CAL 91761
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT rprx-20240930_def.xml EX-101.DEF 397255
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT rprx-20240930_lab.xml EX-101.LAB 764938
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT rprx-20240930_pre.xml EX-101.PRE 543935
75 EXTRACTED XBRL INSTANCE DOCUMENT rprx-20240930_htm.xml XML 1719483
Mailing Address 110 EAST 59TH STREET NEW YORK NY 10022
Business Address 110 EAST 59TH STREET NEW YORK NY 10022 (212) 883-0200
Royalty Pharma plc (Filer) CIK: 0001802768 (see all company filings)

EIN.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39329 | Film No.: 241429419
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)